Diagnosing a Patient with Erdheim-Chester Disease during the COVID-19 Pandemic

<i>Background</i>: Erdheim-Chester disease (ECD) is a rare hematopoietic neoplasm of histiocytic origin characterized by an insidious course. The coronavirus disease 2019 (COVID-19) pandemic has put an enormous strain on healthcare systems worldwide both directly and indirectly, resultin...

Full description

Bibliographic Details
Main Authors: Georgia Kaiafa, Dimitrios Pilalas, Triantafyllia Koletsa, Stylianos Daios, Georgios Arsos, Adam Hatzidakis, Adonis Protopapas, Kostas Stamatopoulos, Christos Savopoulos
Format: Article
Language:English
Published: MDPI AG 2021-09-01
Series:Medicina
Subjects:
Online Access:https://www.mdpi.com/1648-9144/57/10/1001
_version_ 1797513953888174080
author Georgia Kaiafa
Dimitrios Pilalas
Triantafyllia Koletsa
Stylianos Daios
Georgios Arsos
Adam Hatzidakis
Adonis Protopapas
Kostas Stamatopoulos
Christos Savopoulos
author_facet Georgia Kaiafa
Dimitrios Pilalas
Triantafyllia Koletsa
Stylianos Daios
Georgios Arsos
Adam Hatzidakis
Adonis Protopapas
Kostas Stamatopoulos
Christos Savopoulos
author_sort Georgia Kaiafa
collection DOAJ
description <i>Background</i>: Erdheim-Chester disease (ECD) is a rare hematopoietic neoplasm of histiocytic origin characterized by an insidious course. The coronavirus disease 2019 (COVID-19) pandemic has put an enormous strain on healthcare systems worldwide both directly and indirectly, resulting in the disruption of healthcare services to prevent, diagnose and manage non-COVID-19 disease. <i>Case Presentation</i>: We describe the case of a 58-year-old male patient with sporadic episodes of self-resolving mild fever and anemia of chronic disease with onset two years before the current presentation. Positron emission/computed tomography scan revealed the presence of moderately hypermetabolic perirenal tissue masses. In order to achieve diagnosis, repeated perirenal tissue biopsies were performed, and the diagnostic evaluation was complicated by the strain put on the healthcare system by the COVID-19 pandemic. The patient contracted SARS-CoV-2 and required hospitalization, but recovered fully. No further ECD target organ involvement was documented. Treatment options were presented, but the patient chose to defer treatment for ECD. <i>Conclusion</i>: A high index of suspicion and multidisciplinary team collaboration is paramount to achieve diagnosis in rare conditions such as ECD. Disruptions in healthcare services in the pandemic milieu may disproportionately affect people with rare diseases and further study and effort is required to better meet their needs in the pandemic setting.
first_indexed 2024-03-10T06:24:49Z
format Article
id doaj.art-3bf18cc4048d4e108e94987bccee6d19
institution Directory Open Access Journal
issn 1010-660X
1648-9144
language English
last_indexed 2024-03-10T06:24:49Z
publishDate 2021-09-01
publisher MDPI AG
record_format Article
series Medicina
spelling doaj.art-3bf18cc4048d4e108e94987bccee6d192023-11-22T19:03:11ZengMDPI AGMedicina1010-660X1648-91442021-09-015710100110.3390/medicina57101001Diagnosing a Patient with Erdheim-Chester Disease during the COVID-19 PandemicGeorgia Kaiafa0Dimitrios Pilalas1Triantafyllia Koletsa2Stylianos Daios3Georgios Arsos4Adam Hatzidakis5Adonis Protopapas6Kostas Stamatopoulos7Christos Savopoulos8First Propedeutic Department of Internal Medicine, AHEPA University Hospital, Medical School, Aristotle University of Thessaloniki, 54636 Thessaloniki, GreeceFirst Propedeutic Department of Internal Medicine, AHEPA University Hospital, Medical School, Aristotle University of Thessaloniki, 54636 Thessaloniki, GreeceDepartment of Pathology, Medical School, Aristotle University of Thessaloniki, 54124 Thessaloniki, GreeceFirst Propedeutic Department of Internal Medicine, AHEPA University Hospital, Medical School, Aristotle University of Thessaloniki, 54636 Thessaloniki, Greece3rd Department of Nuclear Medicine, Papageorgiou Hospital, Aristotle University of Thessaloniki, 56403 Thessaloniki, GreeceRadiology Department, AHEPA University Hospital, Medical School, Aristotle University of Thessaloniki, 54636 Thessaloniki, GreeceFirst Propedeutic Department of Internal Medicine, AHEPA University Hospital, Medical School, Aristotle University of Thessaloniki, 54636 Thessaloniki, GreeceInstitute of Applied Biosciences, Center for Research and Technology Hellas, 57001 Thessaloniki, GreeceFirst Propedeutic Department of Internal Medicine, AHEPA University Hospital, Medical School, Aristotle University of Thessaloniki, 54636 Thessaloniki, Greece<i>Background</i>: Erdheim-Chester disease (ECD) is a rare hematopoietic neoplasm of histiocytic origin characterized by an insidious course. The coronavirus disease 2019 (COVID-19) pandemic has put an enormous strain on healthcare systems worldwide both directly and indirectly, resulting in the disruption of healthcare services to prevent, diagnose and manage non-COVID-19 disease. <i>Case Presentation</i>: We describe the case of a 58-year-old male patient with sporadic episodes of self-resolving mild fever and anemia of chronic disease with onset two years before the current presentation. Positron emission/computed tomography scan revealed the presence of moderately hypermetabolic perirenal tissue masses. In order to achieve diagnosis, repeated perirenal tissue biopsies were performed, and the diagnostic evaluation was complicated by the strain put on the healthcare system by the COVID-19 pandemic. The patient contracted SARS-CoV-2 and required hospitalization, but recovered fully. No further ECD target organ involvement was documented. Treatment options were presented, but the patient chose to defer treatment for ECD. <i>Conclusion</i>: A high index of suspicion and multidisciplinary team collaboration is paramount to achieve diagnosis in rare conditions such as ECD. Disruptions in healthcare services in the pandemic milieu may disproportionately affect people with rare diseases and further study and effort is required to better meet their needs in the pandemic setting.https://www.mdpi.com/1648-9144/57/10/1001Erdheim-Chester diseaseCOVID-19case report
spellingShingle Georgia Kaiafa
Dimitrios Pilalas
Triantafyllia Koletsa
Stylianos Daios
Georgios Arsos
Adam Hatzidakis
Adonis Protopapas
Kostas Stamatopoulos
Christos Savopoulos
Diagnosing a Patient with Erdheim-Chester Disease during the COVID-19 Pandemic
Medicina
Erdheim-Chester disease
COVID-19
case report
title Diagnosing a Patient with Erdheim-Chester Disease during the COVID-19 Pandemic
title_full Diagnosing a Patient with Erdheim-Chester Disease during the COVID-19 Pandemic
title_fullStr Diagnosing a Patient with Erdheim-Chester Disease during the COVID-19 Pandemic
title_full_unstemmed Diagnosing a Patient with Erdheim-Chester Disease during the COVID-19 Pandemic
title_short Diagnosing a Patient with Erdheim-Chester Disease during the COVID-19 Pandemic
title_sort diagnosing a patient with erdheim chester disease during the covid 19 pandemic
topic Erdheim-Chester disease
COVID-19
case report
url https://www.mdpi.com/1648-9144/57/10/1001
work_keys_str_mv AT georgiakaiafa diagnosingapatientwitherdheimchesterdiseaseduringthecovid19pandemic
AT dimitriospilalas diagnosingapatientwitherdheimchesterdiseaseduringthecovid19pandemic
AT triantafylliakoletsa diagnosingapatientwitherdheimchesterdiseaseduringthecovid19pandemic
AT stylianosdaios diagnosingapatientwitherdheimchesterdiseaseduringthecovid19pandemic
AT georgiosarsos diagnosingapatientwitherdheimchesterdiseaseduringthecovid19pandemic
AT adamhatzidakis diagnosingapatientwitherdheimchesterdiseaseduringthecovid19pandemic
AT adonisprotopapas diagnosingapatientwitherdheimchesterdiseaseduringthecovid19pandemic
AT kostasstamatopoulos diagnosingapatientwitherdheimchesterdiseaseduringthecovid19pandemic
AT christossavopoulos diagnosingapatientwitherdheimchesterdiseaseduringthecovid19pandemic